Triptolide-based treatment prolongs symptom-free survival in preclinical medulloblastoma models

A drug that was developed to treat pancreatic cancer has now been shown to increase symptom-free survival in preclinical medulloblastoma models – all without showing signs of toxicity.

UK clinical trials industry tackles recent changes in the sector – Pharmaceutical Technology

At the Outsourcing in Clinical Trials UK & Ireland 2024 conference, delegates will discuss the UK life sciences landscape and technological advancements in the pharmaceutical

May 20, 2024

Emergent wins $75m BARDA contact for anthrax vaccine

Share this article The current $75m contract option builds on an existing Cyfendus development contract between Emergent and BARDA. Image Credit: Niyazz / Shutterstock. Emergent

November 28, 2023

Unveiling the zoonotic web: Understanding complex interactions involved in zoonoses

Researchers from the Complexity Science Hub and the University of Veterinary Medicine Vienna have dissected the complex interactions involved in zoonoses, which affect worldwide over

July 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.